Skip to main content

Fluidigm Maxpar Imaging Mass Cytometry Kits; CyTOF Software

Fluidigm this week launched three new imaging mass cytometry kits and new CyTOF software at the 2019 World Molecular Imaging Congress.

Fluidigm's Maxpar Human Immuno-Oncology Panel Kits are designed for immune-oncology research. Developed using pathologist-verified antibodies, the panels can be mixed and matched to profile tumor-infiltrating lymphocytes, immune cell activation states, and tissue architecture. By combining them as a single 18-marker panel, researchers can broadly profile activated tumor-infiltrating lymphocytes for single-cell analysis of tumor architecture from a single tissue scan, Fluidigm said.

Fluidigm's CyTOF software, meantime, is designed to be used with the Hyperion Imaging System for cellular biomarker identification. According to the firm, the software streamlines the selection and acquisition of multiple regions of interest (ROI) from each slide. Researchers can remotely annotate those ROIs using brightfield reference images to guide automated batch acquisition of highly multiplexed images at 1-micron resolution. During image acquisition, researchers can visualize multiplexed images in real time across all detection channels to ensure data quality, Fluidigm said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.